Savient Announces Multiple Abstracts Related to KRYSTEXXA® to be Presented at the 2013 ACR/ARHP Annual Meeting

BRIDGEWATER, N.J., Oct. 3, 2013 /PRNewswire/ — Savient Pharmaceuticals, Inc. (Nasdaq: SVNT)today announced that several abstracts related to KRYSTEXXA® (pegloticase) have been selected for presentation at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2013 Annual Meeting.  The 2013 ACR/ARHP annual meeting will be held October 26-30, 2013, in San Diego, CA.

Continue Reading


Tags: , ,

Categories: Life Sciences Industry Network

Author:NJ Tech Council

The New Jersey Tech Council helps companies grow and supports the tech, innovation and entrepreneurial ecosystems in the state and region.

NJTC TechWire

Daily updates about the region's most tech savvy companies

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: